Neurocrine Biosciences (NASDAQ:NBIX) Releases Quarterly Earnings Results

The brief

Neurocrine Biosciences has released its quarterly earnings results. The company reported earnings per share of $2.85, exceeding the consensus estimate. Neurocrine Biosciences operates in the biotechnology sector and is listed on the NASDAQ stock exchange under the ticker symbol NBIX. The quarterly results indicate a return on equity of 19.79% and a net margin of 21.55%. The earnings announcement is significant for investors and stakeholders in the biotechnology industry.

Auto-summarised from the full article